Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Migration of unmigrated content due to installation of a new plugin

Description: 

In this experiment, we are aiming to test whether or not our receptor proteins localize to the cell membrane. To do that, we will have HEK293 cells express LilrB2 and PirB. We will test for membrane localization of the receptors through immunofluorescence. We will use primary antibodies that will bind to LilrB2 and and PirB and secondary antibodies conjugated to fluorophores that will bind to the primary antibodies. 

Cloning

...

COMPLETE

Description:

Making pEXPRs hEF1a:LilrB2 and hEF1a:PirB.

...

 

...

titleProgress = COMPLETE
Status:

...

  • First and second set of liquid cultures didn't grow, possibly because:
    • Too much media
    • Plates were old, antibiotic possibly not working

...

...

  • cells transformed and plated
  • +ve control didn't grow
    • LilrB2 grew blue and white colonies
    • PirB grew white colonies
  • Both liquid cultures grew
  • Miniprepped - Product to be verified
  • pENTRs sent for sequencing - waiting on results 
    • LilrB2 pENTR is correct 
    • PirB pENTR not correct - Q-Q ligation, pENTR only has C terminus end of PirB 
  • New PirB pENTR colonies picked, grown and miniprepped 
    • Restriction digest ran - correct band pattern for one of the colonies
    • Correct colony sent out for sequencing - pENTR has correct sequence

...

  • Restriction digest and gel ran to verify LR products 
    • LilrB2 gave inconclusive results 
      • possible incomplete digestion
    • PirB results did not match expected band pattern 
      • Due to incorrect pENTR 
  • LilrB2 pEXPR sent out for sequencing 
    •  incomplete sequencing results 
    • LilrB2 insert is in the pEXPR

...

  • Restriction digest and gel ran to verify LR products 
    • PirB insert is in the pEXPR
Plan:
  •  Order LilrB2 and PirB gBlocks 
  •  Simulate Golden Gate on Geneious and make sure it works 
  •  Golden Gate gBlocks into ggDONR
  •  Transform bacteria with Golden Gate product and plate 
  •  Pick colonies and grow in liquid culture
  •  Miniprep cells and verify product 
  •  Make glycerol stocks
  •  LR into pDEST
  •  Transform, pick colonies and grow in liquid culture
  •  Miniprep cells and verify product
  •  Make glycerol stocks 
  •  Midiprep product

 

 

 

...

Antibodies:

Antibody
Type
Conjugation
Dilution Used
Link
Anti-LilrB2Mouse monoclonal 

Cytometry: 1/2000

Immunofluorescence: 1/2000

http://www.abcam.com/lilrb2-antibody-ab172538.html
Anti-PirBGoat polyclonal 

Cytometry: 1/2000

Immunofluorescence: 1/2000

http://www.scbt.com/datasheet-9609-Pirb-c-19-antibody.html

Donkey Anti-Goat IgG

 Alexa Fluor 488

Cytometry: 1/2000

Immunofluorescence: 1/200 - 1/1000.

 
Donkey Anti-Mouse IgG 

Alexa Fluor 488

Cytometry: 1/2000

Immunofluorescence: 1/200 - 1/1000.

 

 

LilrB2

TRIAL 1

Transfection Plans:

Expand
titleLilrB2 Trial 1 Transfection Plan
Expand
titleLilrB2 Trial 1 Microscopy Plate
Well 1

B Cells

Well 2

HEK 293

 

 

 

Permeabilized

(Unstained)

Well 3

 HEK293


 

 

Permeabilized

Well 4

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Permeabilized

Well 5

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:LilrB2 (500ng)

Permeabilized

Well 6
Well 7

B Cells

Well 8

HEK 293

 

 

 

Permeabilized

(Unstained)

Well 9

 HEK293

 

 

 

Permeabilized

Well 10

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Permeabilized

Well 11

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:LilrB2 (500ng)

Permeabilized

Well 12

 

Well 13

B Cells

Well 14

HEK 293

 

 

 

Non-Permeabilized

(Unstained)

Well 15

 HEK293

 

 

 

Non-Permeabilized

Well 16

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Non-Permeabilized

Well 17

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:LilrB2 (500ng)

Non-Permeabilized

Well 18
Well 19

B Cells

Well 20

HEK 293

 

 

 

Non-Permeabilized

(Unstained)

Well 21

 HEK293

 

 

 

Non-Permeabilized

Well 22

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Non-Permeabilized

Well 23

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:LilrB2 (500ng)

Non-Permeabilized

Well 24
Expand
titleLilrB2 Trial 1 Cytometry Plate
Well 1

B Cells

Well 2

HEK 293

 

 

 

Well 3

 HEK293

 

Well 4

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate (500ng)

Well 5

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:LilrB2 (500ng)

Well 6
Well 7

B Cells

Well 8

HEK 293

 

 

Well 9

 HEK293

 

 

Well 10

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate (500ng)

Well 11

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:LilrB2 (500ng)

Well 12

 

...


Expand
titleLilrB2 Trial 2 Transfection Plan

Blind Transfection

Well 1

...

Microscopy

PermeabilizedNon-permeabilizedNon-permeabilized stained control 
Image RemovedImage RemovedImage Removed 

Cytometry

Tube 2Tube 3Tube 4Tube 5
Image RemovedImage RemovedImage RemovedImage Removed
  Image RemovedImage Removed
Image RemovedImage RemovedImage RemovedImage Removed
Tube 8Tube 9Tube 10Tube 11
Image RemovedImage RemovedImage RemovedImage Removed

Overlay of 4 and 5:

hef1a:mKate + dummy hef1a:mKate + hef1a:LilrB2  
Image Removed+Image Removed=Image Removed

 

 

HEK293

(Unstained)

Well 2

HEK293

(Stained)

Well 3

HEK293

hEF1a:LilrB2

(Stained)

Well 4

HEK293

(Unstained)

Well 5

HEK293

(Stained)

Well 6

HEK293

hEF1a:LilrB2

(Stained)

Well 7
Well 8
Well 9
Well 10
Well 11
Well 12
Well 13
Well 14
Well 15
Well 16
Well 17
Well 18
Well 19
Well 20
Well 21
Well 22
Well 23
Well 24
Expand
titleLilrB2 Trial 3 Transfection Plan
Fixed and stained

 

Well 1

HEK293

(Unstained)

Well 2

HEK293

(Stained)

Well 3

HEK293

hEF1a:eYFP 500ng

hEF1a:LilrB2 500ng

(Stained)

Well 4

HEK293

(Unstained)

Well 5

HEK293

(Stained)

Well 6

HEK293

hEF1a:eYFP 500ng

hEF1a:LilrB2 500ng

(Stained)

Well 7
Well 8
Well 9
Well 10
Well 11
Well 12
Well 13
Well 14
Well 15
Well 16
Well 17
Well 18
Well 19
Well 20
Well 21
Well 22
Well 23
Well 24
Expand
titleLilrB2 Trial 4 Cytometry Transfection Plan

Blind Transfection

Well 1

HEK293

(Unstained)

Well 2

HEK293

(Stained)

Well 3

HEK293

hEF1a:LilrB2

(Stained)

Well 4

HEK293

(Unstained)

Well 5

HEK293

(Stained)

Well 6

HEK293

hEF1a:LilrB2

(Stained)

Well 7
Well 8
Well 9
Well 10
Well 11
Well 12
Well 13
Well 14
Well 15
Well 16
Well 17
Well 18
Well 19
Well 20
Well 21
Well 22
Well 23
Well 24
Expand
titlePirB

PirB

TRIAL 1

...

Trial 1 Transfection Plan
Expand
titleMicroscopy Plate
Well 1

B Cells

Well 2

HEK 293

 

 

 

Permeabilized

Well 3

 HEK293

+ Dummy

(1000ng)

 

Permeabilized

Well 4

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Permeabilized

Well 5

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Permeabilized

Well 6
Well 7

B Cells

Well 8

HEK 293

 

 

 

Permeabilized

Well 9

 HEK293

+ Dummy

(1000ng)

 

Permeabilized

Well 10

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Permeabilized

Well 11

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Permeabilized

Well 12
Well 13

B Cells

Well 14

HEK 293

 

 

 

Non-Permeabilized

Well 15

 HEK293

+ Dummy

(1000ng)

 

Non-Permeabilized

Well 16

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Non- Permeabilized

Well 17

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Non-Permeabilized

Well 18
Well 19

B Cells

Well 20

HEK 293

 

 

 

Non-Permeabilized

Well 21

 HEK293

+ Dummy

(1000ng)

 

Non-Permeabilized

Well 22

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Non- Permeabilized

Well 23

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Non-Permeabilized

Well 24
Expand
titleCytometry Plate
Well 1

B Cells

Well 2

HEK 293

Well 3

 HEK293

+ Dummy (1000ng)

 

Well 4

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate (500ng)

Well 5

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Well 6
Well 7

B Cells

Well 8

HEK 293

Well 9

 HEK293

+ Dummy (1000ng)

 

Well 10

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate (500ng)

Well 11

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Well 12

 

...


Expand
titlePirB Trial 2 Transfection Plan

Blind Transfection

Well 1

...

HEK293

Image RemovedImage RemovedImage RemovedImage Removed
ControlPermeabilizedNon-permeabilizedLilrB2 Paper

Cytometry

Expand
titleGating
SSC-A vs FSC-AFSC-H vs FSC-WSSC-H vs SSC-WYellow vs Red
Image RemovedImage RemovedImage RemovedImage Removed
Tube 1Tube 2Tube 3Tube 4
Image RemovedImage RemovedImage RemovedImage Removed
Tube 5Tube 6Tube 7Tube 8
Image RemovedImage RemovedImage RemovedImage Removed

TRIAL 2 

...

titleTrial 2

...

Expand
titleMicroscopy Plate
Well 1

B Cells

Well 2

HEK 293

 

 

 

Permeabilized

(Unstained)

Well 3

 HEK293

 

 

 

Permeabilized

Well 4

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Permeabilized

Well 5

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Permeabilized

Well 6
Well 7

B Cells

Well 8

HEK 293

 

 

 

Permeabilized

(Unstained)

Well 9

 HEK293

 

 

 

Permeabilized

Well 10

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Permeabilized

Well 11

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Permeabilized

Well 12
Well 13

B Cells

Well 14

HEK 293

 

 

 

Non-Permeabilized

(Unstained)

Well 15

 HEK293

 

 

 

Non-Permeabilized

Well 16

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Non- Permeabilized

Well 17

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Non-Permeabilized

Well 18
Well 19

B Cells

Well 20

HEK 293

 

 

 

Non-Permeabilized

(Unstained)

Well 21

 HEK293

 

 

 

Non-Permeabilized

Well 22

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate

(500ng)

Non- Permeabilized

Well 23

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Non-Permeabilized

Well 24

...

titleCytometry Plate

(Unstained)

Well 2

HEK293

(Stained)

Well 3

HEK293

hEF1a:PirB

(Stained)

Well 4

HEK293

(Unstained)

Well 5

HEK293

(Stained)

Well 6

HEK293

hEF1a:PirB

(Stained)

Well 7
Well 8
Well 9
Well 10
Well 11
Well 12
Well 13
Well 14
Well 15
Well 16
Well 17
Well 18
Well 19
Well 20
Well 21
Well 22
Well 23
Well 24
Expand
titlePirB Trial 3 Transfection Plan
In this experiment, we're transfecting the receptor fused to YFP to try get some conclusive results as to whether or not the receptor is localizing to the membrane (since the immunostaining didn't give us any results - or rather gave us weird results)

Well 3: control for bleed through

Well 1

HEK293

 

Well 2

HEK293

hEF1a:mKate

Dummy

Well 3

HEK293

hEF1a:PirB-YFP

Dummy

Well 4

HEK293

hEF1a: mKate

hEF1a:PirB-YFP

Well 5

 

Well 6

 

Well 7

HEK293

 

Well 8

HEK293

hEF1a:mKate

Dummy

Well 9

HEK293

hEF1a:PirB-YFP

Dummy

Well 10

HEK293

hEF1a: mKate

hEF1a:PirB-YFP

Well 11
Well 12
Well 13
Well 14
Well 15
Well 16
Well 17
Well 18
Well 19
Well 20
Well 21
Well 22
Well 23
Well 24

Results:

LilrB2

Expand
titleLilrB2 Trial 1

Microscopy

PermeabilizedNon-permeabilizedNon-permeabilized stained control 
Image AddedImage AddedImage Added 


Cytometry

Tube 2Tube 3Tube 4Tube 5
Image AddedImage AddedImage AddedImage Added
  Image AddedImage Added
Image AddedImage AddedImage AddedImage Added
Tube 8Tube 9Tube 10Tube 11
Image AddedImage AddedImage AddedImage Added

Overlay of 4 and 5:

hef1a:mKate + dummy hef1a:mKate + hef1a:LilrB2  
Image Added+Image Added=Image Added

 

 

Expand
titleLilrB2 Trial 2 Microscopy
Well 1

HEK293

(Unstained)

Well 2

HEK293

(Stained)

Well 3

HEK293

hEF1a:eYFP 500ng

hEF1a:LilrB2 500ng

(Stained)

Well 4

HEK293

(Unstained)

Well 5

HEK293

(Stained)

Well 6

HEK293

hEF1a:eYFP 500ng

hEF1a:LilrB2 500ng

(Stained)

  Image Added  Image Added
UntransfectedTransfected
Image AddedImage Added

 

 

Expand
titleLilrB2 Trial 4 Cytometry
Well 1

HEK293

(Unstained)

Well 2

HEK293

(Stained)

Well 3

HEK293

hEF1a:LilrB2

(Stained)

Not gated

Image Added

Non-fluorescent population gated out

Mean: 326

Image Added

 

non-fluorescent population gated out

Mean: 377

Image Added

 

Duplicates

Not gated

Image Added

Non-fluorescent population gated out

Mean: 280

Image Added

Non-fluorescent population gated out

Mean: 358

Image Added

PirB

Expand
titlePirB Trial 1

Microscopy

Image AddedImage AddedImage AddedImage Added
ControlPermeabilizedNon-permeabilizedLilrB2 Paper

Cytometry

Expand
titleGating
SSC-A vs FSC-AFSC-H vs FSC-WSSC-H vs SSC-WYellow vs Red
Image AddedImage AddedImage AddedImage Added
Tube 1Tube 2Tube 3Tube 4
Image AddedImage AddedImage AddedImage Added
Tube 5Tube 6Tube 7Tube 8
Image AddedImage AddedImage AddedImage Added
Expand
titlePirB Trial 3

Well 4 - mKate bleeds into the yellow channel.. a lot.

Red channelYellow channelOverlay
Image AddedImage AddedImage Added

 

 

Negative ControlPirB-YFP only (no transfection marker) 
Image AddedImage Added 

Analysis: 

...

Well 1

B Cells

...

Well 2

HEK 293

...

Well 3

 HEK293

 

 

...

Well 4

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate (500ng)

...

Well 5

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

...

Well 6

...

Well 7

B Cells

...

Well 8

HEK 293

...

Well 9

 HEK293

 

 

...

Well 10

 HEK293

+ Dummy (500ng)

+ hEF1a:mKate (500ng)

...

Well 11

HEK293

+ hEF1a:mKate (500ng)

+ hEF1a:PirB (500ng)

Well 12

 

 

...

 

 

...

Cytometry..

LilrB2 and PirB Trial 1: The plots for the mkate only and mkate + receptor cell populations are very similar. This is most probably due to the bleed through of the red channel into the yellow channel (the 'sensitivity' of the PMTs for the yellow channel was increased because the yellow fluorophore was not very bright).

Next steps:

  • We are going to transfect the receptors without using a transfection marker (Trial 2).

Microscopy..

   Immunostaining 

LilrB2 and PirB Trial 1: For both the receptors, there doesn't seem to be any clear localization of the receptors to the membrane. From the punctate appearance of the cells under the confocal, they seem to be significant localization of the receptors in some subcellular cytoplasmic structure. They may be making it to the membrane; however we are unable to discern that just from the images. Interestingly, this cytoplasmic localization seems to be apparent in the non-permeabilized cells which may mean that the fixing protocol is causing some kind of permeabilization in the cells. It may be of significance to note that in the LilrB2 paper (the one we are trying to replicate), they expressed the receptors under CMV (not hEF1a). Depending on the relative strengths of the promoters, the differing levels of expression (probably higher expression through hEF1a) might be causing the staining pattern that we are seeing.

Next steps:

  • Perhaps staining live cells (to skip the fixation step) and hopefully conclude whether or not some of the receptor is making it to the membrane. (We are also going to do the beta amyloid binding experiment despite being unsure whether or not the receptor is making it to the membrane in hopes that it does bind and we can conclude that it is localizing.)
  • Once we get the receptor-fluorescent protein fusions out of cloning, we can express them and look for localization. This will tell us whether or not the staining pattern that we're seeing is due to the protein expression or the staining.
  • Clone the receptors into a different promoter: CMV or a TRE to determine if high expression levels are the problem. Having inducible expression of the receptors may be helpful later on in determining what the optimal level of receptor expression for the system.

   YFP fusion 

Evidence is not super convincing that the yellow that we are seeing is not just autofluorescence given that we see something very similar in our negative control. It is likely that PirB is not getting expressed at all, or that the fusion is disturbing it's structure somehow making it not localize to the membrane (the happier scenario). mKate bleedthrough into the yellow channel was an issue. Ideally, we would make an eBFP fusion but considering how hard it was to make the fusions in the first place, that isn't really a feasible solution, we can possibly look into using an IR protein as a transfection marker (Trial 4). Also, it is probably a good idea to DAPI counterstain next time. Zstacks with nuclear staining will help in determining membrane localization (or lack thereof).

Next steps:

  • Is the receptor even getting expressed? Maybe if we transfect TRE:receptor-YFP and run a dox ladder, we can conclude on whether or not there is expression based on whether or not there are varying levels of yellow corresponding to the dox ladder.
  • Run PirB Trial 3 again but with an IR fluorescent transfection marker to try and eliminate bleedthrough (Trial 4)